RGC
Regencell Bioscience Holdings Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK
$6.71
−2.19%Latest reported
- Last report date
- Oct 28, 2026
- EPS actual
- -$0.01
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 28, 2026 | — | -$0.01 | — | — |
| Jun 15, 2026 | — | -$0.01 | — | — |
| Jan 24, 2025 | — | -$0.14 | — | — |
| Jan 26, 2024 | — | $0.00 | — | — |
| Jun 30, 2023 | — | -$0.01 | — | — |
| Jan 30, 2023 | — | -$0.01 | — | — |
| Jun 30, 2020 | — | $0.00 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 28, 2026